stomach paralysis semaglutide Ozempic Lawsuit [2026 Update] GLP-1 Medications Could Cause Stomach

The oral form of semaglutide opens the door to more patients, offering convenience and a simpler approach to managing weight loss

WEGOVY (semaglutide) injection 2.4 mg is an injectable prescription medicine used with a reduced calorie diet and increased physical activity to treat adults with metabolic dysfunction-associated steatohepatitis (MASH) with moderate to advanced liver scarring (fibrosis), but not with cirrhosis of the liver This indication is approved based on improvement of MASH and liver scarring (fibrosis)

The findings suggest that a higher dose of semaglutide offers a promising new option for people with obesity, including those with T2D, who have not achieved sufficient weight loss with existing treatments

The weight loss injections provided act as a supplement to a healthy lifestyle, but taking personal steps toward better health is still advised

Who Is Hims Not For

GLP-1 agonists have shown to be highly effective at managing diabetes and obesity, which are major health concerns across the population